Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Archives of Disease in Childhood - Fetal and Neonatal Edition 2006;91:F448-F453; doi:10.1136/adc.2005.082263
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow erratum
Right arrow Correction (v92,pF156)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anand, K J S
Right arrow Articles by Hall, R W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anand, K J S
Right arrow Articles by Hall, R W

REVIEW

Pharmacological therapy for analgesia and sedation in the newborn

K J S Anand, R W Hall

Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

Correspondence to:
Correspondence to:
K J S Anand
Arkansas Children’s Hospital, 800 Marshall Street, Little Rock, AR 72202, USA;anandsunny{at}exchange.uams.edu


ABSTRACT
Rapid advances have been made in the use of pharmacological analgesia and sedation for newborns requiring neonatal intensive care. Practical considerations for the use of systemic analgesics (opioids, non-steroidal anti-inflammatory agents, other drugs), local and topical anaesthetics, and sedative or anaesthetic agents (benzodiazepines, barbiturates, other drugs) are summarised using an evidence-based medicine approach, while avoiding mention of the underlying basic physiology or pharmacology. These developments have inspired more humane approaches to neonatal intensive care. Despite these advances, little is known about the clinical effectiveness, immediate toxicity, effects on special patient populations, or long-term effects after neonatal exposure to analgesics or sedatives. The desired or adverse effects of drug combinations, interactions with non-pharmacological interventions or use for specific conditions also remain unknown. Despite the huge gaps in our knowledge, preliminary evidence for the use of neonatal analgesia and sedation is available, but must be combined with a clear definition of clinical goals, continuous physiological monitoring, evaluation of side effects or tolerance, and consideration of long-term clinical outcomes.


Abbreviations: IVH, intraventricular haemorrhage; NSAID, non-steroidal anti-inflammatory drug; PVL, periventricular leucomalacia; RCT, randomised controlled trial




This article has been cited by other articles:


Home page
Nurs EthicsHome page
A. Axelin and S. Salantera
Ethics in Neonatal Pain Research
Nursing Ethics, July 1, 2008; 15(4): 492 - 499.
[Abstract] [PDF]


Home page
EDUCATION AND PRACTICEHome page
J E. Harrop
Management of pain in childhood
Arch. Dis. Child. Ed. Pract., August 1, 2007; 92(4): ep101 - ep108.
[Full Text] [PDF]

eLetters:

Read all eLetters

Non-steroidal anti-inflammatory drugs and neonatal analgesia:
Karel allegaert, et al.
Fetal Neonatal Ed. Online, 15 Nov 2006 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health